An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: A description of 3 cases

Pain Physician

Volumn 14, Issue 5, 2011, Pages 483-489

  Harned, Michael E ^a   Salles, Sara S ^a   Grider, Jay S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Baclofen; Intrathecal drug delivery; Multiple sclerosis; Spasticity; Traumatic brain injury

Indexed keywords

BACLOFEN; OPIATE; TIZANIDINE;

ADULT; ARM DISEASE; ARTICLE; CASE REPORT; CHRONIC PAIN; CONTINUOUS INFUSION; CONTRACTURE; COORDINATION; DIFFUSE AXONAL INJURY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DYSTONIA; FEMALE; HEMIPARETIC SPASTICITY; HUMAN; INDWELLING CATHETER; LEG DISEASE; LIMB WEAKNESS; MALE; MODIFIED ASHWORTH SCALE; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PHYSIOTHERAPY; QUALITY OF LIFE; RATING SCALE; REHABILITATION CARE; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; SOMNOLENCE; SPASTICITY; TERTIARY HEALTH CARE; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY;

ADULT; BACLOFEN; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PAIN MEASUREMENT; PARESIS;

EID: 80052852101     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity [letter]. Lancet 1984; 1:1078.
2. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Physician 2011; 14:219-248.
3. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
4. Deer TR, Smith HS, Burton AW, Pope JE, Doleys DM, Levy RM, Staats Peter S, Wallace MS, Webster LR, Rauck RL, Cousins M. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 2011; 14: E283-E312.
5. Haley SM, Inacio CA. Evaluation of spasticity and its effect on motor function. In: Glenn MB, Whyte J(eds). The Practical Management of Spasticity in Children and Adults. Lea & Febiger, Malvern, PA, 1990, pp 115-126.
6. Krach LE. Pharmacotherapy of spasticity: Oral medications and intrathecal baclofen. J Child Neurol 2001; 16:31-36.
7. Albright AL. Spastic cerebral palsy; approaches to drug treatment. CNS Drugs 1995; 4:17-27.
8. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991; 265:1418-1422.
9. Murphy, NA, Irwin MCN, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Arch Phys Med Rehabil 2002; 83:1721-1725.
10. Rawicki B. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: Long-term follow-up review of 18 patients. J Neurosurg 1999; 91:733-736.
11. Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol 2003; 18:26-34.
12. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192:540-542.
13. Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF. What does the Ashworth Scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol 2002; 44:112-118.
14. Raffaili W, Sarti D, Demartini L, Sotgiu A, Bonezzi C, Italian Ziconotide Group. Italian Registry on long-term intrathecal ziconotide treatment. Pain Physician 2011; 14: 15-24.
15. Lima RM, Navarro LH, Carness JM, Barros GA, Margues ME, Solanki D, Ganem EM. Clinical and histological effects of the intrathecal administration of methylprednisolone in dogs. Pain Physician 2010; 13:493-501.
16. Kapoor R, Liu J, Devasenapathy A, Gordin V. Gadolinium encephalopathy after intrathecal gadolinium injection. Pain Physician 2010; 13: E321-E326.
17. Ruan X, Couch JP, Liu HN, Shah RV, Wang F, Chiravuri S. Respiratory failure following delayed intrathecal morphine pump refill: A valuable, but costly lesson. Pain Physician 2010; 13:337-341.
18. Dureja GP, Usmani H, Khan M, Tahseen M, Jamal A. Efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of postherpetic neuralgia involving lumbosacral dermatomes. Pain Physician 2010; 13:213-221.
19. Deer TR, Smith HS, Cousins M, Doleys DM, Levy RM, Rathmell JP, Staats PS, Wallace MS, Webster LR. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician 2010; 13:E1750-E213.
20. Wilkes D, Cook M, Solanki D. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: A case report. Pain Physician 2010; 13:151-156.
21. Burton AW, Deer TR, Wallace MS, Rauck RL, Grigsby E. Considerations and methodology for trialing ziconotide. Pain Physician 2010; 16:23-33.
22. Deer TR, Kim C, Bowman R, Tolentino D, Stewart C, Tolentino W. Intrathecal ziconotide and opioid combination therapy for noncancer pain: An observational report. Pain Physician 2009; 12:E291-E296.
23. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360
24. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician 2009; 12:699-802.
25. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993; 270:2475-2477.
26. Flückiger B, Knecht H, Grossmann S, Felleiter P. Device-related complications of long-term intrathecal drug therapy via implanted pumps. Spinal Cord 2008; 46:639-643.
27. Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS. Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002; 83:735-741.
28. Green LB, Nelson VS. Death after acute withdrawal of intrathecal baclofen: Case report and literature review. Arch Phys Med Rehabil 1999; 80:1600-1604.
29. Steinbok P., O'Donnell M. Baclofen infusion for spastic cerebral palsy. Clin Neurosurg 2000; 47:440-57.
30. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320:1517-1521.
31. Grabb P, Guin-Renfroe S, Meythaler JM. Midthoracic catheter tip placement for intrathecal baclofen administration children with quadriparetic spasticity. Neurosurgery 1999; 45:833-840.